Clinical Trial Update: PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 prospective trial at Tianjin Medical University Eye Hospital to optimize atropine concentration escalation for preventing myopia in children at risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• atropine sulfate ophthalmic solution (atropine sulfate)

Snippet

Sponsor: Tianjin Medical University Eye Hospital | Conditions: Pre-myopia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING